BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  BrainLAB AG and SurgiVision, Inc. Announce Strategic Alliance in MRI-Guided Drug Delivery and Other Interventional MRI Technologies in Neurosurgery

  April 11, 2011

   · 

  4 min read
• Biotech Beach

  Webcast and Conference Call Alert: Isis Pharmaceuticals, Inc. Holds Webcast to Discuss Recent Advances in its Development Pipeline

  April 11, 2011

   · 

  1 min read
• Biotech Beach

  The Next Generation in Bilevel Therapy Now Available on ResMed Inc.'s Award-Winning S9(TM) Platform

  April 11, 2011

   · 

  6 min read
• Drug Development

  Vanda Pharmaceuticals, Inc. Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt(R)

  April 11, 2011

   · 

  4 min read
• BioMidwest

  TechniScan Medical Systems’ Breast Imaging Science Featured at National Ultrasound Conference

  April 11, 2011

   · 

  3 min read
• Drug Development

  Novartis Pharmaceuticals Corporation Therapy Gilenya(TM) Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows

  April 11, 2011

   · 

  10 min read
• Pharm Country

  Auxilium Pharmaceuticals Announces Launch of XIAPEX(R) in EU by Pfizer Inc.

  April 11, 2011

   · 

  7 min read
• Business

  PAREXEL International Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market

  April 11, 2011

   · 

  5 min read
• Compass Biotechnologies Inc (COBI: OB) Announces Its Subsidiary Company C-Pharma to Focus on Hepatitis Franchise While Compass Focuses on Biosimiliar and Bio-Better Near Term Revenue Products

  April 11, 2011

   · 

  4 min read
• Policy

  FDA Cancels MannKind Corporation Meeting on Shutdown Danger

  April 11, 2011

   · 

  2 min read